within Pharmacolibrary.Drugs.ATC.V;

model V04CX08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.03,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Carbon monoxide is a colorless, odorless, and tasteless gas. In medical applications, it is used primarily as a diagnostic agent for measuring diffusing capacity of the lung (DLCO test) in pulmonary function testing, and experimentally as a research tool. It is not approved as a therapeutic drug but is administered under strict clinical conditions for diagnostic assessment. Carbon monoxide has high affinity for hemoglobin, displacing oxygen to form carboxyhemoglobin.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic model exists for carbon monoxide as a drug in standard clinical use. Carbon monoxide is typically administered by inhalation in diagnostic settings at very low concentrations (e.g., 0.3% in air, single breath or up to several minutes), and parameters such as absorption are governed by pulmonary uptake and binding to hemoglobin. No peer-reviewed publications were found providing compartment model parameters such as volume of distribution or clearance in the classic drug sense.</p><h4>References</h4><ol><li><p>Steiger, C, et al., &amp; Meinel, L (2017). Localized delivery of carbon monoxide. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 118 3–12. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2016.11.002&quot;>10.1016/j.ejpb.2016.11.002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27836646/&quot;>https://pubmed.ncbi.nlm.nih.gov/27836646</a></p></li><li><p>Kind, T (2005). Carbon monoxide. <i>Pediatrics in review</i> 26(4) 150–151. DOI:<a href=&quot;https://doi.org/10.1542/pir.26-4-150&quot;>10.1542/pir.26-4-150</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16552941/&quot;>https://pubmed.ncbi.nlm.nih.gov/16552941</a></p></li><li><p>Adach, W, &amp; Olas, B (2019). Carbon monoxide and its donors - their implications for medicine. <i>Future medicinal chemistry</i> 11(1) 61–73. DOI:<a href=&quot;https://doi.org/10.4155/fmc-2018-0215&quot;>10.4155/fmc-2018-0215</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30526059/&quot;>https://pubmed.ncbi.nlm.nih.gov/30526059</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V04CX08;
